Skip to content
Search

Latest Stories

Submit Guest Post

Apsana Begum’s trial in housing fraud case begins today

Apsana Begum’s trial in housing fraud case begins today

A LONDON court was scheduled to begin on Wednesday (21) the trial of Apsana Begum, the Labour MP for Poplar and Limehouse, in a case of alleged council housing fraud.

Snaresbrook Crown Court is expected to hold the hearing for six to eight days and the MP is exempted from providing her address in the charge details.


Begum, 31, was investigated over whether she wrongly secured a social housing flat from the Tower Hamlets Council and how her name got to the top of a waiting list of 18,000 applicants quickly.

She also faces charges of dishonestly failing to disclose information.

The Labour politician, who previously denied any wrongdoing, said on Wednesday (21) that she is “vigorously contesting” the charges.

“The ongoing legal proceedings mean that I cannot and will not be making any further public comment during the trial,” she said in a statement.

The British Bangladeshi MP thanked her lawyers and supporters for their help.

Begum, who won the Poplar and Limehouse parliamentary seat in East London with a majority vote of 28,904, is regarded as the UK's first MP to wear the hijab in Parliament.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Wegovy pills

Pharmacists have raised concerns that fake Wegovy tablets could emerge following the drug's UK launch

iStock

Wegovy pills could fuel UK's black market, experts warn

  • UK launches its first Wegovy weight loss tablet.
  • Pharmacists warn counterfeit pills could enter the black market.
  • Nearly all surveyed pharmacies expect fake medicines to become a bigger risk.

The launch of the Wegovy weight loss pill in the UK is expected to make obesity treatment more accessible, but pharmacists are warning it could also fuel a growing trade in fake weight loss medicines. The oral version of the popular drug became available on Tuesday (7), just weeks after receiving approval from the UK's medicines regulator.

According to a report by the BBC, pharmacy leaders believe the tablet form of semaglutide could be easier for criminal gangs to copy than the existing injectable version, increasing the risk of counterfeit medicines being sold online and through unlicensed suppliers.

Keep ReadingShow less